TradingView
warrenhochfeld
2017年11月2日晚上8點44分

Dynavax breakout ahead of Heplisav approval 看多

Dynavax Technologies CorporationNASDAQ

描述

Start of final bull run ahead of 9th November FDA announcement of Heplisav approval
$25-$30 price projection
更多